Top States: CA | DC | FL | GA | MA | NC | NJ | NY | OH | TX | WA |

Cancer Cure Lottery: 10 Vaccine Treatments to Be Given Away Over 5-Week Period

By :: Tue, 13 Sep 2011 03:55:01 -0400 EDT

regenerative cellular cancer treatmentsKIRKLAND, Wash., Sept. 13, 2011 (SEND2PRESS NEWSWIRE) — Regenerative Cellular Therapy (RCT) of Puerto Penasco, Sonora, Mexico, is holding its first annual treatment giveaway. Over the next five weeks, starting September 13, two lucky winners per week will receive state-of-the-art regenerative cellular cancer treatments free of charge.

The winners will be selected at random in five weekly lottery drawings. Any cancer sufferer may enter by submitting an online form, at http://www.facebook.com/CellularTherapy .

Regenerative cellular therapy, such as that offered by RCT, is not yet available in the U.S., but U.S. citizens are eligible to enter the lottery. If they win, however, they must travel to Mexico at their own expense, but “100 percent of the treatment costs will be covered by us,” says Dr. Oscar E. Castro, RCT’s onsite physician.

RCT’s E+ Peptide cancer vaccine offers a powerful, non-invasive key to tumor destruction. By conducting an exchange of information through the p53 gene, the gene orders cellular self-destruction rather than multiplication, through a process called apoptosis. The vaccine is appropriate for treating many types of cancer, and the manufacturers have been active in their fields for over thirty years.

RCT is located on the grounds of the luxury Bella Sirena resort.

A brochure and additional information, including a link to the RCT site, are available at http://www.facebook.com/CellularTherapy . Information may also be requested by email or phone: contact @ rctherapy.net, (480) 626-4845 (USA office) or (638) 382-8011 (Mexico office).

News Source: Regenerative Cellular Therapy :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®. View all current news at: http://Send2PressNewswire.com .

More Information:

Press Release Copr. © Regenerative Cellular Therapy (or “news source”) and Send2Press® Newswire. Permission granted for reproduction by news portals, aggregators and news indexes provided original attribution to this site and news source is retained. Cannot be used for commercial purposes/advertising or keyword marketing. All other rights reserved.

This press release has had 1,732 views so far.
http://www.send2press.com/newswire/2011-09-0913-001.shtml
 
The window below features the website for the “news source” it is not part of, nor managed by, Send2Press® Newswire.
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the "news source." The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this Web site) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or the Send2Press® Newswire service. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.